SAMANTHA NIGH: Open Payments
NPI 1205873734 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 92 payments from 25 companies in 2025. Trend: 2023 $1,047 · 2024 $1,581 · 2025 $2,152
Food & beverage: $2,013Education: $138
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $283 |
| ABBVIE INC. | 8 | $261 |
| PFIZER INC. | 8 | $254 |
| AstraZeneca Pharmaceuticals LP | 7 | $222 |
| SOBI, INC | 7 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $156 |
| Aveo Pharmaceuticals, Inc. | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Genentech USA, Inc. | 2 | $76 |
| Dendreon Pharmaceuticals LLC | 3 | $75 |
Products named: EPKINLY, Nubeqa, FOTIVDA, IMFINZI, ADCETRIS, XTANDI, PLUVICTO, SCEMBLIX.
Industry payments across OK — which companies pay providers there.
